Skip to main content

Animations

MJFF Publications

5551 - 5560 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2011
  • 2014
  • 2014
  • 2013
  • 2016
  • 2012
  • Summary Details
    RESTRICTED
    Title: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Obesity, diabetes, and risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23855
    Citation Count: 160
  • Summary Details
    OPEN
    Title: Treatment of myoclonus-dystonia syndrome with tetrabenazine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.029
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2014.06.014
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faa
    Citation Count: 197
  • Summary Details
    OPEN
    Title: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control Subjects
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-160888
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.014
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.